Ciprofloxacin and dexamethasone suspension
Reason category: Other
FDA recall number D-0626-2025
Antibiotic
Ciprofloxacin 500 mg tablet
Public data on ciprofloxacin from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
$0.1206
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-19%
change over five years
peak $0.2512 in 2015-04
22
approved generic applications (ANDAs) on record for Ciprofloxacin Hydrochloride
13 with a product still marketed · first 2004
Not listed
in FDA's current shortage list
Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops: To Be Discontinued
NADAC per unit, monthly
CIPROFLOXACIN HCL 500 MG TABShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.13689 |
| 2014-02 | 0.14521 |
| 2014-05 | 0.14330 |
| 2014-08 | 0.14291 |
| 2014-11 | 0.19248 |
| 2015-02 | 0.17730 |
| 2015-05 | 0.25121 |
| 2015-08 | 0.24115 |
| 2015-11 | 0.17333 |
| 2016-02 | 0.18027 |
| 2016-05 | 0.17808 |
| 2016-08 | 0.16425 |
| 2016-11 | 0.15614 |
| 2017-02 | 0.14527 |
| 2017-05 | 0.15010 |
| 2017-08 | 0.14909 |
| 2017-11 | 0.14782 |
| 2018-02 | 0.14049 |
| 2018-05 | 0.11552 |
| 2018-08 | 0.12027 |
| 2018-11 | 0.11047 |
| 2019-02 | 0.10669 |
| 2019-05 | 0.10961 |
| 2019-08 | 0.12515 |
| 2019-11 | 0.12049 |
| 2020-02 | 0.12604 |
| 2020-05 | 0.12960 |
| 2020-08 | 0.10655 |
| 2020-11 | 0.11622 |
| 2021-02 | 0.13332 |
| 2021-05 | 0.14120 |
| 2021-08 | 0.15152 |
| 2021-11 | 0.14801 |
| 2022-02 | 0.14617 |
| 2022-05 | 0.15197 |
| 2022-08 | 0.15502 |
| 2022-11 | 0.15376 |
| 2023-02 | 0.15432 |
| 2023-05 | 0.14876 |
| 2023-08 | 0.14772 |
| 2023-11 | 0.15515 |
| 2024-02 | 0.15909 |
| 2024-05 | 0.13498 |
| 2024-08 | 0.13922 |
| 2024-11 | 0.12667 |
| 2025-02 | 0.13193 |
| 2025-05 | 0.14247 |
| 2025-08 | 0.13985 |
| 2025-11 | 0.13625 |
| 2026-02 | 0.12962 |
| 2026-05 | 0.11431 |
| 2026-08 | 0.12455 |
| 2026-11 | 0.12065 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning ciprofloxacin
openFDA enforcement records, by year reported.
| 2025 | 4 |
| 2024 | 1 |
| 2023 | 1 |
| 2022 | 4 |
| 2021 | 1 |
| 2019 | 3 |
| 2017 | 2 |
| 2016 | 2 |
| 2015 | 3 |
| 2014 | 2 |
28 records since 2012. A record is one product or lot, not one recall event. Combination products that contain ciprofloxacin are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Ciprofloxacin product
Reason category: Other
FDA recall number D-0364-2025
Ciprofloxacin ophthalmic solution
Reason category: Other
FDA recall number D-0282-2025
Ciprofloxacin ophthalmic solution
Reason category: Other
FDA recall number D-0182-2025
Ciprofloxacin ophthalmic solution
Reason category: Other
FDA recall number D-0623-2024
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention ciprofloxacin
4 GxRadar articles cite or discuss this drug.
Price histories · Data story · 5 min
Nitrofurantoin and the antibiotic price story
Pharmacies paid $1.77 for a nitrofurantoin capsule in January 2014 and 28 cents in October 2026. How six oral antibiotics' prices diverged, why competition explains much of it, and where shortages fit.
Using medicines safely · Explainer · 5 min
How drug expiration dates are set
What the expiration date on a medicine means under federal rules, how stability testing produces it, what the federal Shelf Life Extension Program found, and when FDA has allowed use past labeled dates during shortages.
Labels & identifiers · Explainer · 5 min
Medication Guides and patient package inserts
What 21 CFR Part 208 requires, when a pharmacy must hand over a Medication Guide, how patient package inserts differ, and where FDA's one-page replacement proposal stands.
Causes & tracking · Explainer · 6 min
Why antibiotics keep running short
Seven anti-infectives were on FDA's current shortage list in October 2026, one of them since 2015, and 30 more had discontinuation notices. Low prices and few makers explain much of it, federal research shows.